Real-time enrollment status for this hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: October 23, 2026 at 1:16 PM UTC
| NCT Number | NCT05039073 |
| Recruiting Status | Recruiting |
| Condition | Hodgkin Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 46 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | September 8, 2026 (Sep 8, 2026) |
As of October 23, 2026: Clinical trial NCT05039073 is currently recruiting participants. This phase2 study for hodgkin lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05039073 is actively recruiting participants as of October 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05039073 was last updated Sep 8, 2026 (September 8, 2026). HelloStudys verifies this status automatically.